|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61F 9/00 | (2006.01) |
| A61M 39/0208 | (2013.01) | ||
| A61F 9/008 | (2006.01) | ||
| A61F 9/0017 | (2013.01) |
| (11) | Number of the document | 2978393 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14720436.6 |
| Date of filing the European patent application | 2014-03-27 | |
| (97) | Date of publication of the European application | 2016-02-03 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/032056 |
| Date | 2014-03-27 |
| (87) | Number | WO 2014/160884 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 201361806267 P | 2013-03-28 | US |
| (72) |
ERICKSON, Signe , US
CAMPBELL, Randolph, E. , US
DOUD, Darren , US
|
| (73) |
ForSight Vision4, Inc. ,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | OPHTHALMIC IMPLANT FOR DELIVERING THERAPEUTIC SUBSTANCES |
| OPHTHALMIC IMPLANT FOR DELIVERING THERAPEUTIC SUBSTANCES |